Galectin Therapeutics logo

Galectin Therapeutics Share Price Today

(NASDAQ: GALT)

Galectin Therapeutics share price is $1.57 & ₹136.54 as on 6 Mar 2025, 2.30 'hrs' IST

$1.57

-0.02

(-1.26%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Galectin Therapeutics share price in Dollar and Rupees. Guide to invest in Galectin Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Galectin Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Galectin Therapeutics share price movements

  • Today's Low: $1.54
    Today's High: $1.62

    Day's Volatility :4.94%

  • 52 Weeks Low: $0.73
    52 Weeks High: $4.27

    52 Weeks Volatility :82.99%

Galectin Therapeutics (GALT) Returns

PeriodGalectin Therapeutics IncIndex (Russel 2000)
3 Months
-25.42%
0.0%
6 Months
-35.66%
0.0%
1 Year
-24.52%
0.0%
3 Years
26.61%
-11.6%

Galectin Therapeutics (GALT) Key Statistics

in dollars & INR

Previous Close
$1.59
Open
$1.61
Today's High
$1.62
Today's Low
$1.54
Market Capitalization
$98.5M
Today's Volume
$238.7K
52 Week High
$4.2684
52 Week Low
$0.726041
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.73
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-3727.95%

How to invest in Galectin Therapeutics Stock (GALT) from India?

It is very easy for Indian residents to invest directly in Galectin Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Galectin Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Galectin Therapeutics or GALT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Galectin Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Galectin Therapeutics shares which would translate to 0.554 fractional shares of Galectin Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Galectin Therapeutics, in just a few clicks!

Returns in Galectin Therapeutics (GALT) for Indian investors in Rupees

The Galectin Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Galectin Therapeutics investment value today

Current value as on today

₹80,430

Returns

₹19,570

(-19.57%)

Returns from Galectin Therapeutics Stock

₹24,519 (-24.52%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Galectin Therapeutics (GALT)

0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Galectin Therapeutics Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Galectin Therapeutics

  • Vanguard Group Inc

    3.41%

  • BlackRock Inc

    2.63%

  • Advisor Group Holdings, Inc.

    1.88%

  • Geode Capital Management, LLC

    1.39%

  • Sontag Advisory LLC

    0.63%

  • Geneos Wealth Management Inc

    0.62%

Analyst Recommendation on Galectin Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Galectin Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Galectin Therapeutics Stock (GALT)

What analysts predicted

Upside of 600.64%

Target:

$11.00

Current:

$1.57

Insights on Galectin Therapeutics Stock (Ticker Symbol: GALT)

  • Price Movement

    In the last 7 days, GALT stock has moved up by 6.1%
  • GALT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 91.0%

Galectin Therapeutics Technicals Summary

Sell

Neutral

Buy

Galectin Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Galectin Therapeutics (GALT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Galectin Therapeutics Inc logo
25.6%
-35.66%
-24.52%
26.61%
26.61%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Galectin Therapeutics Inc logo
NA
NA
0.0
0.0
-37.28
-0.97
NA
-1.52
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Galectin Therapeutics Inc logo
Buy
$98.5M
26.61%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Galectin Therapeutics

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, that is in Phase 2b/3 clinical trial, to prevent esophageal varices in patient with non-alcoholic steatohepatitis (NASH) cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Organization
Galectin Therapeutics
Employees
14
CEO
Mr. Joel Lewis CPA
Industry
Health Technology

Management People of Galectin Therapeutics

NameTitle
Mr. Joel Lewis CPA
President, CEO & Director
Mr. Jack W. Callicutt CPA
CFO, Treasurer & Corporate Secretary
Mr. Robert Tritt J.D.
General Counsel
Mr. Jeff Katstra
Head of CMC & Pharmaceutical Development
Dr. Khurram Jamil M.D.
Chief Medical Officer
Ms. Beth Knowles
Executive Assistant & Officer Manager

Important FAQs about investing in GALT Stock from India :

What is Galectin Therapeutics share price today?

Galectin Therapeutics share price today stands at $1.57, Open: $1.61 ; Previous Close: $1.59 ; High: $1.62 ; Low: $1.54 ; 52 Week High: $4.27 ; 52 Week Low: $0.73.

The stock opens at $1.61, after a previous close of $1.59. The stock reached a daily high of $1.62 and a low of $1.54, with a 52-week high of $4.27 and a 52-week low of $0.73.

Can Indians buy Galectin Therapeutics shares?

Yes, Indians can invest in the Galectin Therapeutics (GALT) from India.

With INDmoney, you can buy Galectin Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Galectin Therapeutics at zero transaction cost.

How can I buy Galectin Therapeutics shares from India?

It is very easy to buy Galectin Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Galectin Therapeutics (GALT) be purchased?

Yes, you can buy fractional shares of Galectin Therapeutics with INDmoney app.

What are the documents required to start investing in Galectin Therapeutics stocks?

To start investing in Galectin Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Galectin Therapeutics Stock (GALT)?

Today’s highest price of Galectin Therapeutics (GALT) is $1.62.

Today’s lowest price of Galectin Therapeutics (GALT) is $1.54.

What is today's market capitalisation of Galectin Therapeutics?

Today's market capitalisation of Galectin Therapeutics GALT is 98.5M

What is the 52 Week High and Low Range of Galectin Therapeutics Stock (GALT)?

  • 52 Week High

    $4.27

  • 52 Week Low

    $0.73

What are the historical returns of Galectin Therapeutics (GALT)?

  • 1 Month Returns

    25.6%

  • 3 Months Returns

    -35.66%

  • 1 Year Returns

    -24.52%

  • 5 Years Returns

    26.61%

Who is the Chief Executive Officer (CEO) of Galectin Therapeutics ?

Mr. Joel Lewis CPA is the current Chief Executive Officer (CEO) of Galectin Therapeutics.